- Home
- OPTX vs CNTB Comparison
OPTX vs CNTB Comparison
Compare OPTX & CNTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPTX
- CNTB
- Stock Information
- Founded
- OPTX 1981
- CNTB 2012
- Country
- OPTX United States
- CNTB United States
- Employees
- OPTX N/A
- CNTB N/A
- Industry
- OPTX Blank Checks
- CNTB Biotechnology: Pharmaceutical Preparations
- Sector
- OPTX Finance
- CNTB Health Care
- Exchange
- OPTX Nasdaq
- CNTB Nasdaq
- Market Cap
- OPTX 51.9M
- CNTB 43.2M
- IPO Year
- OPTX N/A
- CNTB 2021
- Fundamental
- Price
- OPTX $1.46
- CNTB $0.79
- Analyst Decision
- OPTX
- CNTB Strong Buy
- Analyst Count
- OPTX 0
- CNTB 1
- Target Price
- OPTX N/A
- CNTB $8.00
- AVG Volume (30 Days)
- OPTX 62.9K
- CNTB 68.9K
- Earning Date
- OPTX 06-13-2025
- CNTB 05-15-2025
- Dividend Yield
- OPTX N/A
- CNTB N/A
- EPS Growth
- OPTX N/A
- CNTB N/A
- EPS
- OPTX 0.00
- CNTB N/A
- Revenue
- OPTX $29,392,186.00
- CNTB $26,033,000.00
- Revenue This Year
- OPTX N/A
- CNTB N/A
- Revenue Next Year
- OPTX N/A
- CNTB N/A
- P/E Ratio
- OPTX $840.96
- CNTB N/A
- Revenue Growth
- OPTX 4.36
- CNTB N/A
- 52 Week Low
- OPTX $0.85
- CNTB $0.51
- 52 Week High
- OPTX $8.39
- CNTB $2.07
- Technical
- Relative Strength Index (RSI)
- OPTX 46.02
- CNTB 50.92
- Support Level
- OPTX $1.51
- CNTB $0.73
- Resistance Level
- OPTX $1.59
- CNTB $0.85
- Average True Range (ATR)
- OPTX 0.17
- CNTB 0.06
- MACD
- OPTX -0.03
- CNTB -0.00
- Stochastic Oscillator
- OPTX 22.41
- CNTB 51.07
About OPTX Syntec Optics Holdings Inc.
Syntec Optics Holdings Inc is vertically integrated from design and component manufacturing for lens system assembly to imaging module integration for system solutions. Making its tools, molding, and nano machining allows close interaction and recut ability, enabling special techniques to hold tolerances to sub-micron levels. It has steadily developed a variety of other complementary manufacturing techniques to provide a wide suite of horizontal capabilities including thin film deposition coatings, glass molding, polymer molding, tool-making, mechanical manufacturing, and nano machining.
About CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.